ENTITY
DM1001
DM1001
PulseAugur coverage of DM1001 — every cluster mentioning DM1001 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-07-24 product_launch Fosun Wanbang received approval for clinical trials of DM1001 for Parkinson's disease. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
China Metallurgical Group reports 24.5% drop in new contracts; Fosun Pharma gets trial approval
China Metallurgical Group Corporation (MCC) reported a 24.5% year-over-year decrease in new contract value for the first half of 2026, totaling 413.64 billion yuan. The second quarter alone saw a 34.6% decline in new co…
-
Fosun Pharma subsidiary gets nod for Parkinson's drug trial
Fosun Pharmaceutical has announced that its subsidiary, Fosun Wanbang, has received approval from the National Medical Products Administration to conduct clinical trials for DM1001, a treatment for idiopathic Parkinson'…